Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Grover

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Biochimica Et Biophysica Acta|December 4, 2003
Sarcolemmal and mitochondrial effects of a KATP opener, P-1075, in "polarized" and "depolarized" Langendorff-perfused rat heartsOlga Jilkina, Bozena Kuzio, Gary J Grover, et al.
Life Sciences|December 1, 2010
Effects of the soluble fiber complex PolyGlycopleX® (PGX®) on glycemic control, insulin secretion, and GLP-1 levels in Zucker diabetic ratsGary J Grover, Lee Koetzner, Joan Wicks, et al.
The Journal of Nutrition|August 24, 2012
Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker ratsRaylene A Reimer, Gary J Grover, Lee Koetzner, et al.
Neuroreport|April 13, 2004
The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioningBela Kis, Krisztina Nagy, James A Snipes, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
In vivo characterization of the mitochondrial selective K(ATP) opener (3R)-trans-4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): cardioprotective, hemodynamic, and electrophysiological effectsGary J Grover, Albert J D'Alonzo, Raymond B Darbenzio, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2007
Pharmacological profile of the thyroid hormone receptor antagonist NH3 in ratsGary J Grover, Celeste Dunn, Ngoc-Ha Nguyen, et al.
Journal of Molecular and Cellular Cardiology|September 12, 2003
P1075 opens mitochondrial K(ATP) channels and generates reactive oxygen species resulting in cardioprotection of rabbit heartsOlaf Oldenburg, Xi-Ming Yang, Thomas Krieg, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 17, 2004
Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activityGary J Grover, Karnail S Atwal, Paul G Sleph, et al.
Journal of Medicinal Chemistry|February 20, 2004
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitorsKarnail S Atwal, Paulina Wang, W Lynn Rogers, et al.
Endocrinology|January 1, 2004
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronineGary J Grover, Donald M Egan, Paul G Sleph, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta|December 4, 2003
Sarcolemmal and mitochondrial effects of a KATP opener, P-1075, in "polarized" and "depolarized" Langendorff-perfused rat heartsOlga Jilkina, Bozena Kuzio, Gary J Grover, et al.
Life Sciences|December 1, 2010
Effects of the soluble fiber complex PolyGlycopleX® (PGX®) on glycemic control, insulin secretion, and GLP-1 levels in Zucker diabetic ratsGary J Grover, Lee Koetzner, Joan Wicks, et al.
The Journal of Nutrition|August 24, 2012
Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker ratsRaylene A Reimer, Gary J Grover, Lee Koetzner, et al.
Neuroreport|April 13, 2004
The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioningBela Kis, Krisztina Nagy, James A Snipes, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
In vivo characterization of the mitochondrial selective K(ATP) opener (3R)-trans-4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): cardioprotective, hemodynamic, and electrophysiological effectsGary J Grover, Albert J D'Alonzo, Raymond B Darbenzio, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2007
Pharmacological profile of the thyroid hormone receptor antagonist NH3 in ratsGary J Grover, Celeste Dunn, Ngoc-Ha Nguyen, et al.
Journal of Molecular and Cellular Cardiology|September 12, 2003
P1075 opens mitochondrial K(ATP) channels and generates reactive oxygen species resulting in cardioprotection of rabbit heartsOlaf Oldenburg, Xi-Ming Yang, Thomas Krieg, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 17, 2004
Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activityGary J Grover, Karnail S Atwal, Paul G Sleph, et al.
Journal of Medicinal Chemistry|February 20, 2004
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitorsKarnail S Atwal, Paulina Wang, W Lynn Rogers, et al.
Endocrinology|January 1, 2004
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronineGary J Grover, Donald M Egan, Paul G Sleph, et al.
Pageof 4